136 related articles for article (PubMed ID: 12381443)
1. Cytogenetic survey of 117 Tunisian patients with de novo myelodysplastic syndrome.
Sendi HS; Hichri H; Elghezal H; Gribaa M; Laatiri A; Elloumi M; Ben Lakhal R; Saad A
Ann Genet; 2002; 45(3):131-5. PubMed ID: 12381443
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
Gmidène A; Sennana H; Fenaux P; Laatiri A; Zarrouk M; Bouaziz H; Harrabi I; Saad A
Leuk Res; 2008 Dec; 32(12):1824-9. PubMed ID: 18556065
[TBL] [Abstract][Full Text] [Related]
3. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic analysis of 54 cases of myelodysplastic syndrome.
Jotterand-Bellomo M; Parlier V; Schmidt PM; Beris P
Cancer Genet Cytogenet; 1990 Jun; 46(2):157-72. PubMed ID: 2340487
[TBL] [Abstract][Full Text] [Related]
5. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
6. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
[TBL] [Abstract][Full Text] [Related]
7. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
[TBL] [Abstract][Full Text] [Related]
10. [Chromosome abnormalities in myelodysplastic syndrome].
Fujita K; Mori H; Niikura H; Terada H; Shinohara T
Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
12. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 11 abnormalities in myelodysplastic syndromes.
Collado R; Badía L; García S; Sánchez H; Prieto F; Carbonell F
Cancer Genet Cytogenet; 1999 Oct; 114(1):58-61. PubMed ID: 10526536
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
Jacobs RH; Cornbleet MA; Vardiman JW; Larson RA; Le Beau MM; Rowley JD
Blood; 1986 Jun; 67(6):1765-72. PubMed ID: 3708160
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
[TBL] [Abstract][Full Text] [Related]
16. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
17. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
Vila L; Charrin C; Archimbaud E; Treille-Ritouet D; Fraisse J; Felman P; Fiere D; Germain D
Blut; 1990 Apr; 60(4):223-7. PubMed ID: 2337681
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
[TBL] [Abstract][Full Text] [Related]
20. [Cytogenetic study of 93 myelodysplastic syndromes].
Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
